Rapid Extraction Technique Prepares Urine Samples for Mass Spectrometry Analysis
|
By LabMedica International staff writers Posted on 07 Jun 2015 |

Image: The centrifugation step is the key to removing protein biomarkers from urine\'s high salt matrix (Photo courtesy of Clemson University).
Disposable mini-tubes packed with capillary-channeled polymer (C-CP) fibers have been adapted for the rapid extraction of proteins from urine specimens for analysis by MALDI-MS (matrix-assisted laser desorption/ionization mass spectrometry).
While mass spectrometry is a powerful tool for biomarker determinations, the high salt content and the matrix of small molecules present in urine has reduced its applicability for urinary diagnosis. To correct this deficiency, investigators at Clemson University (SC, USA) packed micropipette tips with C-CP fibers. These fibers possess a unique geometry that includes eight channels that extend the entire fiber length (which can be miles on a spool). The fibers are nominally an oblong shape with diameters ranging from 35 to 50 micrometers, with the individual channels ranging in size from five to 20 micrometers.
Urine samples were passed through fiber-packed tubes by spinning them in a centrifuge for 30 seconds. Following centrifugation de-ionized water was run through the tubes for one minute to wash off salt and other contaminants. Hydrophobic proteins, which remained bound to the fibers, were extracted for MALDI-MS analysis with appropriate solvents during a 30 second centrifugation step.
Matrix-assisted laser desorption/ionization (MALDI) is a soft ionization technique used in mass spectrometry, allowing the analysis of biomolecules (biopolymers such as DNA, proteins, peptides, and sugars) and large organic molecules (such as polymers, dendrimers, and other macromolecules), which tend to be fragile and fragment when ionized by more conventional ionization methods. It is similar in character to electrospray ionization (ESI) in that both techniques are relatively soft ways of obtaining ions of large molecules in the gas phase, though MALDI produces far fewer multiply charged ions.
The C-CP fiber method was validated by measuring the urinary proteins beta-2-microglobulin, retinol binding protein, and transferrin. C-CP fiber tips offered several advantages including low materials costs, high throughput, microvolume processing, and the determination of sub-nanogram quantities of analyte; allowing determination of biomarkers that are otherwise undetectable in urine samples.
"You have got almost seawater coming out of you, and I am trying to find something far smaller than a needle in a haystack," said senior author Dr. Ken Marcus, professor of analytical chemistry at Clemson University. "The concentrations of these proteins would be one part in a billion."
The C-CP fiber method for urine sample purification was described in the March 18, 2015, online edition of the journal Proteomics-Clinical Applications.
Related Links:
Clemson University
While mass spectrometry is a powerful tool for biomarker determinations, the high salt content and the matrix of small molecules present in urine has reduced its applicability for urinary diagnosis. To correct this deficiency, investigators at Clemson University (SC, USA) packed micropipette tips with C-CP fibers. These fibers possess a unique geometry that includes eight channels that extend the entire fiber length (which can be miles on a spool). The fibers are nominally an oblong shape with diameters ranging from 35 to 50 micrometers, with the individual channels ranging in size from five to 20 micrometers.
Urine samples were passed through fiber-packed tubes by spinning them in a centrifuge for 30 seconds. Following centrifugation de-ionized water was run through the tubes for one minute to wash off salt and other contaminants. Hydrophobic proteins, which remained bound to the fibers, were extracted for MALDI-MS analysis with appropriate solvents during a 30 second centrifugation step.
Matrix-assisted laser desorption/ionization (MALDI) is a soft ionization technique used in mass spectrometry, allowing the analysis of biomolecules (biopolymers such as DNA, proteins, peptides, and sugars) and large organic molecules (such as polymers, dendrimers, and other macromolecules), which tend to be fragile and fragment when ionized by more conventional ionization methods. It is similar in character to electrospray ionization (ESI) in that both techniques are relatively soft ways of obtaining ions of large molecules in the gas phase, though MALDI produces far fewer multiply charged ions.
The C-CP fiber method was validated by measuring the urinary proteins beta-2-microglobulin, retinol binding protein, and transferrin. C-CP fiber tips offered several advantages including low materials costs, high throughput, microvolume processing, and the determination of sub-nanogram quantities of analyte; allowing determination of biomarkers that are otherwise undetectable in urine samples.
"You have got almost seawater coming out of you, and I am trying to find something far smaller than a needle in a haystack," said senior author Dr. Ken Marcus, professor of analytical chemistry at Clemson University. "The concentrations of these proteins would be one part in a billion."
The C-CP fiber method for urine sample purification was described in the March 18, 2015, online edition of the journal Proteomics-Clinical Applications.
Related Links:
Clemson University
Latest Clinical Chem. News
- AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers
- Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
- Blood Metabolite Test Detects Early Cognitive Decline
- AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
- Automated NfL Assay Supports Monitoring of Neurological Disorders
- Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
- New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
- CSF Biomarker Improves Diagnosis of Parkinson’s Disease and Lewy Body Dementia
- Simple Urine Home Test Kit Could Detect Early-Stage Breast Cancer
- Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
- New Tool Tracks Biomarker Changes to Predict Myeloma Progression
- New Plasma Tau Assay Improves Prediction of Alzheimer’s Progression
- First IVD Immunoassay to Detect Alzheimer’s Risk Gene Variant Receives CE Mark
- Routine Blood Markers Predict Heart Failure Risk in Prediabetes
- AI Model Enables Personalized Glucose Predictions for Type 1 Diabetes
- AI-Powered Blood Test Distinguishes Deadly Cardiac Events
Channels
Clinical Chemistry
view channel
AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers
Cardiovascular diseases are a leading cause of death, responsible for nearly 20 million deaths each year. Timely triage of myocardial infarction and heart failure hinges on rapid cardiac biomarker measurement,... Read moreNext Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read moreMolecular Diagnostics
view channel
Genome Sequencing Identifies Noncoding Variants Causing Neonatal Diabetes
Neonatal diabetes is a rare form of diabetes that presents in the first six months of life and is driven by genetic changes, yet many affected families still lack definitive diagnoses. Genetic studies... Read more
Genetic Markers Predict GLP-1 Weight-Loss Response and Side Effects
Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide and tirzepatide are now widely used for weight management, yet individual responses vary considerably, with some patients experiencing... Read moreHematology
view channel
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
Chronic myelomonocytic leukemia (CMML) is a rare blood cancer in which acquired genetic mutations in bone marrow stem cells drive disease. Stem cell transplantation is the only curative option but carries... Read more
New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
Monitoring response to antiplatelet therapy remains challenging for many clinical laboratories. Aggregation-based assays and cartridge systems often require specialized personnel, dedicated instruments,... Read moreImmunology
view channelCombined Screening Approach Identifies Early Leprosy Cases
Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read more
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspots
Intensive care units face persistent threats from hospital-acquired infections, increasingly driven by drug-resistant bacteria. Rapidly pinpointing environmental reservoirs and transmission hotspots remains... Read more
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read morePathology
view channelAI Improves Completeness of Complex Cancer Pathology Reports
Oncology teams increasingly rely on pathology reports that integrate histopathology, immunohistochemistry, and rapidly expanding biomarker testing. As patients live longer and undergo repeated analyses... Read more
AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer mortality worldwide, with China bearing nearly half of the global burden. Only a subset of patients benefit from... Read moreIndustry
view channel
GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR
GRAIL’s Galleri multi-cancer early detection (MCED) test is being integrated into Epic’s electronic health record (EHR) platform through Epic Aura. The collaboration is designed to let clinicians at interested... Read moreGlobal Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership on April 2, 2026 to broaden access to operationally streamlined next-generation sequencing (NGS) tumor profiling for... Read more







